Category Archives: Robotics

Pictured is the CRH team working with the Robotic Navigation and Cone Beam CT with Augmented Fluoroscopy to diagnose lung cancer earlier. Cone Beam CT Guided Robotic bronchoscopy will be a huge next step for the CRH pulmonary program, which is led by Lung Institute director and interventional pulmonologist Dr. Deepankar Sharma.

Columbus Regional Health has started using new technology that includes a human-controlled robotic arm in an effort to help detect and diagnose lung cancer Bartholomew Countys top cancer killer.

The technology, which the hospital system started using Nov. 3, involves an assortment of tools that create a 3D map of the patients lungs and help doctors guide a catheter attached to a robotic arm through the narrow passageways of the lungs, said Dr. Deepenkar Deep Sharma, an interventional pulmonologist at CRH and director of the hospital systems Lung Institute.

The robotic arm, which a doctor controls at a console next to the patient, allows doctors to reach hard-to-navigate areas inside the lungs in a less invasive way and perform biopsies on masses that were either previously too small or very difficult to reach.

The technology is Robotic Navigation and Cone Beam CT with Augmented Fluoroscopy, designed to diagnose lung cancer earlier.

So far, CRH has used to the new technology on about 10 patients with great results, said Sharma, who is optimistic that the new technology will play a key role in diagnosing a cancer that state records suggest is responsible for one in three cancer deaths in Bartholomew County.

Lung cancer killed 983 Bartholomew County residents from 1999 to 2019 318 more deaths than breast, colon and prostate cancers combined, according to the most recent data from the Indiana Department of Health. In 2019, 53 of the 161 cancer deaths in the county were attributed to lung cancer.

The biggest hope with all this is to be able to identify lung cancer and other serious lung problems while they are still in early stages, Sharma said. Survival is dependent on when you catch it.

The launch of the new technology comes at as fears mount among local health officials that the pandemic disrupted screenings and other preventive care that may have caught cancers that before they reached later stages, when the chances of survival are far more uncertain.

It also comes after state health officials reported that lung cancer deaths in Bartholomew County rose 51% from 2017 to 2019, reaching the highest annual tally since 2012.

In 2019, 53 Bartholomew County residents died of lung cancer, up from 35 in 2017, according to state records released earlier this year. Data for 2020 is not yet available.

Though the impact of the pandemic on cancer care may not be fully known for some time, CRH has already seen an increase in cancer diagnoses so far this year.

About 18% of the 83 cancers detected through the hospital systems lung cancer screening program since 2017 were found during the first six months of this year, according to figures provided by Sharma.

We are definitely seeing more cancer diagnoses in 2021 due to the gap in care that happened due to the pandemic, Sharma said.

Lung cancer is the nations biggest cancer killer and is expected to cause about 131,800 deaths this year, according to the American Cancer Society. Smoking is responsible for about 90% of lung cancer cases, according to the American Lung Association. At least 70 chemicals found in tobacco smoke have been found to cause cancer.

Yet most lung cancers are diagnosed too late for doctors to dramatically improve the chances of survival. Stage 1 lung cancer has a 90% survival rate, while stage 4 has a survival rate of less than 5%. But a patient can progress from stage 1 to stage 4 in just a few weeks, Sharma said.

Indiana has the eighth highest lung cancer rate in the country, according to a recent study by the American Lung Association. Just 7% of people Indiana who are at a high risk for lung cancer get screened and 1 in 5 Hoosiers with lung cancer never get treatment

CRH, for its part, has found a lung cancer prevalence rate through its screening program that is more than twice as high as the rate found in an authoritative national study of high-risk individuals diagnosed with the disease.

Since 2017, CRH officials have regularly seen a prevalence rate between 2% and 2.5%, compared to a national rate of about 1%, Sharma said. About 80% of local cases have directly or indirectly involved smoking.

The last three years, we consistently have maintained twice the cancer incidence through our screening program, Sharma said.

But many Bartholomew County residents who are at especially high risk can get an annual low-dose CT scan to detect lung cancer at an early stage when survival is far more likely. The screenings are non-invasive, painless and take around five minutes to complete, CRH officials said previously.

The U.S. Preventive Services Task Force recommends that anyone ages 50 and 80 who has smoked at least 20 pack-years and still smokes or has quit within the past 15 years, according to the Centers for Disease Control and Prevention. A pack-year means smoking the equivalent of one pack of cigarettes per day for a year.

Currently, CRH is on pace to perform more than 1,000 screenings this year, up from about 800 last year.

In matter of a few weeks, you can go from being cancer-free forever versus not having even a year to live, Sharma said.

More:

CRH using specialized robotics to detect county's top cancer death cause - The Republic

Through subsidiary - Madhumala Ventures

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, November 24 2021. 16:09 IST

See more here:

Pidilite Industries to acquire 19.51% in Constrobot Robotics - Business Standard

LONDON, Nov. 24, 2021 /CNW/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its Real Intelligence brand of enabling technology solutions, as well as its next generation handheld robotics platform - the CORI Surgical System - in Canada.

Smith+Nephew's CORI Surgical System

Real Intelligence will address clinical challenges through the continuum of care including patient engagement, pre-operative planning, digital and robotic surgery, post-operative assessment and outcomes measurement. Each solution in the Real Intelligence digital ecosystem informs the next phase of treatment, and over time will allow healthcare providers to use outcomes data to make more informed decisions in how they treat their patients. The CORI Surgical System will stand at the center of the Real Intelligence brand and is now available for both total and unicompartmental knee arthroplasty.

"With the introduction of the CORI Surgical System, we have a handheld robotic-assisted platform that is especially well suited to meet the needs of the Canadian marketplace," said Dave O'Neil, Vice President and Managing Director, Canada for Smith+Nephew. "The CORI System does not require CT or pre-op imaging and has the potential to improve both implant placement accuracy1-5,* and OR efficiency.6,** It is a fraction of the size of other robotic platforms on the market*** and represents the first step of Smith+Nephew's long-term strategy to change the way orthopaedic surgeons treat their patients here in Canada."

Smith+Nephew plans to continue to introduce new applications for this robotics platform, expanding beyond knee procedures and into other orthopaedic pathologies.

"I am very excited to start using Smith+Nephew's CORI Surgical System to deliver the benefits of robotic-assisted surgery directly to my patients," said Dr. Douglas Naudie, Orthopaedic Surgeon and Professor, Western University. "The handheld robot coupled with intuitive software helps to accurately size and position the components and optimize ligament balance. The entire system is efficient and portable - a welcome combination for a crowded operating room."

Story continues

The CORI Surgical System has received Health Canada approval and is available for sale in Canada. For more information, please visist http://www.real-intelligence.com.

Reference

Battenberg AK, Netravali NA, Lonner JH. A novel handheld robotic-assisted system for unicompartmental knee arthroplasty: surgical technique and early survivorship. J Robot Surg. 2019.

Batailler C, White N, Ranaldi FP, et al. Improved implant position and lower revision rate with robotic assisted unicompartmental knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2019;27:1232.

Herry Y BC, Lording T, Servien E, Neyret P, Lustig S. Improved joint-line restitution in unicompartmental knee arthroplasty using a robotic-assisted surgical technique. Int Orthop. 2017;41:2265-2271.

Gregori A, Smith JR, Picard F, Lonner JH, Jaramaz B. Accuracy of imageless robotically assisted unicondylar knee arthroplasty. Paper presented at: International Society for Computer Assisted Orthopaedic Surgery (CAOS) 15th Annual Meeting; 2015; Vancover, Canada.

Bollars P, Boeckxstaens A, Mievis J, Kalaai S, Schotanus MGM, Janssen D. Preliminary experience with an imagefree handheld robot for total knee arthroplasty: 77 cases compared with a matched control group. Eur. J. Orthop Surg Traumatol. 2020;30(4):723-9

Smith+Nephew 2020. Tray Reduction Claim - References Consolidation. Internal Report

Smith+Nephew 2020. Comparison of operating room footprint for robotic-assisted knee arthroplasty systems. Internal Report. EO.REC.PCS015.002.v1.

*Compared to conventional techniques**Reduced number of trays required for CORI UKA & TKA procedures compared to conventional procedures. Using the JOURNEY II implant family***Compared to Mako and ROSA systems

About Smith+NephewSmith+Nephew is a portfolio medical technology business that exists to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 18,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Advanced Wound Management and Sports Medicine & ENT.

Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $4.6 billion in 2020. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.

For more information about Smith+Nephew, please visit http://www.smith-nephew.com and follow us on Twitter, LinkedIn, Instagram or Facebook.

Forward-looking StatementsThis document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: risks related to the impact of COVID-19, such as the depth and longevity of its impact, government actions and other restrictive measures taken in response, material delays and cancellations of elective procedures, reduced procedure capacity at medical facilities, restricted access for sales representatives to medical facilities, or our ability to execute business continuity plans as a result of COVID-19; economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers (including, without limitation, as a result of COVID-19); price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers (including, without limitation, as a result of COVID-19); competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.

Trademark of Smith+Nephew. Certain marks registered US Patent and Trademark Office.

Smith & Nephew logo. (PRNewsFoto/Smith & Nephew)

SOURCE Smith & Nephew plc

Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2021/24/c8005.html

Go here to see the original:

Smith+Nephew launches Real Intelligence and CORI Surgical System; next generation handheld robotics platform in Canada - Yahoo Finance

LONDON--(BUSINESS WIRE)--Technology that lets humans teleport into robots thousands of miles away could soon help with nuclear decommissioning and disaster recovery.

Created by robotics company Cyberselves, the tech allows human operators to see, hear and feel through a robot, allowing them to complete tasks as if they were really there.

The technology could provide remote support in hazardous environments, for telemedicine and space exploration.

The invention has won a spot in the finals of the ANA Avatar XPRIZE global robotics competition.

The $10 million four-year global competition focuses on the development of an avatar system to deploy a humans senses, actions, and presence to a remote location in real time.

Cyberselves telepresence technology lets users teleport into a robot from long distances. This could make it easier for humans to safely carry out hazardous tasks, including nuclear decommissioning, bomb disposal and offshore wind production.

In the Miami semi-finals, the avatar robots overcame three challenges: completing a childrens jigsaw puzzle, raising a wine glass for a toast, and lifting a vase to feel its texture.

Daniel Camilleri, co-founder and CTO at Cyberselves said: We are incredibly proud to have made it into the finals. Our Teleport app makes the remote operation of robots both powerfully effective and functionally simple. Sending signals through our cloud-based, low-latency communications platform, Animus, a movement made by a human operator in Europe could be carried out almost simultaneously by a robot in the United States.

The competition began with 97 teams. 37 of these made it into the semi-finals, with only 15 chosen to move forward into the final stage.

David Locke, executive prize director of the ANA Avatar XPRIZE said: The cutting-edge technology we witnessed at semi-finals testing has the potential to entirely reimagine the human experience. Were excited to see how teams further fine-tune their technology systems as we lead up to finals testing.

Junko Yazawa, senior vice president of All Nippon Airways (ANA), which sponsors the Avatar XPRIZE, said of the finalists: We are really proud of their achievements so far with their innovative Avatar technology that will most definitely be an important part of our future in travel and human connections.

The finals in Autumn 2022 will see teams compete to win a share of $8M.

ENDS

See the original post:

Cyberselves Tech Lets Humans Teleport Into Robots on the Other Side of the World - Business Wire

iStock by Getty Images

According toMordor Intelligence, the U.S. medical robotics market is expected to reach $28.34 billion by 2026. These next-generation systems promise lower costs, less hardware, smaller incisions, more precise treatment, increased levels of guidance and automation.

But big market predictions are often vague on the specifics. Where specifically is the market opportunity for robotically assisted symptoms? What are the challenges manufacturers face in the highly regulated medical tools market? What are the market drivers and technological advancements behind the trends?

I caught up withDarren Porras, Market Development Manager of Medical atReal-Time Innovations(RTI), for a look at what's really happening (and what's coming down the pike) for the medical robotics market.

GN: In what procedures have medical robots become standard? Why those procedures, and what does that say about the earliest iterations of the technology?

Darren Porras:Robotically-assisted systems are increasingly being used today for a broad array of procedures: General Surgeries (e.g. GI, Colorectal), Urological, Gynecological, Neurovascular, Orthopedic (hip/knee implants), and Spinal procedures. These systems provide greater control of surgical instruments and improved visualization to enable more precise and reproducible treatment. For patients, this means less trauma and faster recovery times.

Laparoscopic robotic systems that consist of surgeon-controlled instruments inserted through abdominal ports are the most commercially available systems today to surgically treat a number of cancers, including prostate, bladder, and rectal cancers.

While the initial laparoscopic robotic systems expanded upon the already established minimally-invasive approach for laparoscopic procedures, these systems continue to evolve, and other form factors and device architectures are now in use and emerging. For orthopaedic and spinal procedures, robotic arms and intelligent hand-held devices are assisting surgeons in guiding tools for precise placement and treatments. Flexible robotic systems incorporate steerable catheters, bronchoscopes, and other devices to perform lung biopsies and percutaneous cardiovascular interventions. These systems provide deeper access into internal anatomy and through natural orifices.

GN: Given the market for medical interventions and the evolving technologies, where are the big market opportunities for medical robots, and why is that the case?

Darren Porras:Market opportunity in healthcare is really about how to most effectively and efficiently improve patient care and outcomes. The role of robotics in augmenting surgical tasks during the procedure is only a part of this. The digital transformation in healthcare is redefining how patients are diagnosed, treated, and monitored. This transformation incorporates devices, intelligence, and interoperability of systems and data prior to surgery, during surgery, and for follow-up after surgery. Device manufacturers that develop robotic platforms that integrate holistically and seamlessly with the clinical workflow and leverage data-driven technologies across the device ecosystem will transform minimally invasive surgery.

It's important to note that the majority of surgeries being performed today are not robotic or even minimally invasive. There is a significant opportunity for robotics across all procedure types to improve surgical treatments and patient care. As surgical procedures increasingly utilize data and interoperable intelligent systems to realize clinical efficiencies, assist in decision-making, and automate procedural tasks, robotics will play a key role in meeting the needs of healthcare systems and patients.

GN: Can you speak to some of the challenges manufacturers still face, particularly in areas like system development and issues like safety/reliability, interoperability, and cyber security?

Darren Porras:These systems pose many technical challenges and new computing paradigms. Evolving technologies and increasing complexity presents a steep learning curve to development teams and a lot of risk. With many competitors entering the market and the need to accelerate feature development, companies must focus their teams on what differentiates their products and leverage state of the art technologies, tools, and reusable reference architectures.

Surgical robotics are complex, distributed systems of computing nodes, cameras, sensors, instruments, and other devices that all must work as one integrated system. It's a data connectivity challenge with a number of simultaneous and demanding requirements for reliability, performance, cybersecurity, and interoperability.

Cybersecurity is a big concern. While regulatory bodies, device manufacturers, and hospitals are increasingly collaborating to improve the security of devices and hospital systems, cybersecurity breaches are now a common occurrence. The threat landscape has changed- a couple of teenagers with tools readily available on the internet can launch ransomware attacks and bring down medical devices and vulnerable hospital networks. The consequences of a breach can lead to patient harm, product recalls, and exponential costs to companies that may also include disclosure of trade secrets/IP. Regulatory bodies are raising the bar for approval with updated cybersecurity guidance and increased scrutiny. Device manufacturers must design secure communications into the product at the "white-board" stage across the device ecosystem to secure data components across multi-domain networks while satisfying demanding performance requirements and diverse use cases for system and data access.

These challenges require new software architectures and state-of-the-art, distributed connectivity solutions that enable intelligent, secure, and real-time connectivity across devices, systems, and network domains from the edge to the cloud. Beyond APIs, connectivity frameworks are needed that enable interoperable, reliable, and flexible architectures that are scalable. Device manufacturers can't afford to redesign their systems or update hardware whenever they release new features. Leveraging connectivity frameworks enables development teams to focus on their core competencies and application development- thereby accelerating time to market.

GN: What's on the horizon in terms of capabilities? How will AI and automation play a bigger role going forward?

Darren Porras:Robotic systems will increasingly become 'digital platforms' that leverage data integration and intelligent connectivity across devices to enhance the surgical procedure itself while also being an integral part of a digital surgery ecosystem. By leveraging this interoperability of systems of systems, the power of the convergence of these technologies will truly transform patient care. This requires increasing integration of imaging, visualization, and intelligence through dedicated but increasingly distributed systems and networks.

Device and edge-distributed processing are increasingly important for safety-critical robotics applications where key requirements are latency, reliability, and security. This distributed architecture allows systems to process data locally to execute intelligent device functionality efficiently. Remote-teleoperation is another exciting area where we are already seeing systems capable of performing remote surgeries across 5G networks. These capabilities allow surgeons worldwide to collaborate, enable greater access to expert treatments, and reach remote and underserved populations.

AI algorithms will enhance the sensing capabilities of surgical instrumentation based on physiological parameters and sensor fusion (e.g. blood perfusion, temperature, pressure sensors). AI will also be leveraged to realize increasing levels of surgical precision, autonomous functionality, and consistency of surgical procedures.

Leveraging data, visualization, and intelligence across distributed devices and networks, these systems will provide real-time guidance during the procedure while also assisting in pre-operative surgical planning and post-operative device and procedure optimization. For example, data and metrics collected from the procedure may be used to provide feedback to improve the next surgery and train other surgeons. Clinical teams across the world may leverage this data to collaborate, advance, and standardize surgical treatments. This offers an incredible opportunity to provide universal access to high-quality care and patient outcomes.

GN: What's your sense of the market appetite for medical robots within both the medical and patient communities? Any pushback from healthcare workers? Any reticence among patient populations?

Darren Porras:The high cost of these systems is one key barrier. With new competitors entering the market and as the designs of these systems continue to evolve, it's anticipated that these factors will drive down costs.

Another barrier is the learning curve required by the clinical teams to operate and the difficulty in incorporating these systems into the clinical workflow and hospital ecosystem. Robotically-assisted systems have made great strides in the technical arena- but that's not sufficient to transform surgery. A system may incorporate the most innovative technology. Still, if the technology is inaccessible, whether due to cost factors, insufficiently trained staff, regulatory constraints, or unavailable due to reliability or security issues- this presents a significant hurdle. Device companies need to incorporate best practices in system design and security and evolve functionality quickly to meet the needs of the clinical teams, the hospitals, and the patients.

As the utilization of robotic systems grows and these systems demonstrate value and improved patient care across the care cycle, this will continue to fuel further adoption. While there is a perception that surgeons will be "replaced", this is not actually the way increasing automation usually plays out in a highly skilled industry. Industry professionals need to collaborate with clinical stakeholders to embrace how procedures can optimally incorporate robotics to elevate what is possible to be done in surgery today and standardize more precise surgical treatments to a greater patient population.

At the end of the day, nobody resists what is best for the patient. Patients are calling for technologies that enable the most effective treatments, faster recoveries, and reduced complications. As technology continues to transform patient care, medical device manufacturers must adapt to the needs of the patient, the procedures, and the clinical teams. Surgeons are already taking advantage of the benefits of improved ergonomics, greater visibility, and the ability to treat patients earlier and with higher precision. These systems will continue to improve the automation of surgical tasks and the clinical workflow. By leveraging intelligent and distributed connectivity, it will be difficult to imagine surgeries without robots in the not-too-distant future.

See the original post:

What's really happening in the medical robotics market - ZDNet

People will be quite sceptical for getting knee replacement surgery because of the opinions from various people. Sukhjit Sandhu was also the same about getting her knee replacement surgery after she witnessed how her husband always had some muscle pain when he walked or stood for a long time. His knee bending and range of motion also became limited, despite the passing of three years from the date of his surgery. Seeing his poor condition, despite the fear, her surgery was successful, and she went back to her normal life within a couple of days of her replacement.

Sandhu is one of the hundreds of happy patients to have successfully undergone robotics-assisted total knee replacement surgery since the launch of the internationally acclaimed and proven NAVIO Robotics Surgical System in India.

Originally developed in the US and approved by the US FDA after elaborate pre-clinical, clinical, and technical assessments for years, the system boasts of assisting surgeons across major hospitals in the US, Europe, Australia, and India, with thousands of patients benefiting every year from its precision, unparalleled results, and advanced Artificial Intelligence (AI) that helps these surgeons deliver patient satisfaction at the highest level so far.

Conventional knee replacement vs robotics knee replacement

Though conventional joint replacement is a successful and safe procedure, out of the nearly 2,10,000 joint replacement procedures done every year in India, roughly 25 percent of the operated patients are still unsatisfied with their outcomes. That is close to 50,000 unhappy patients due to residual pain, restricted mobility, and an overall compromised lifestyle. Why does that happen despite skillful surgeons, bone cutting tools and some great hospital infrastructure in the non-robotic surgeries?

It's primarily because there is still a lot of room for improvement to overcome human error and complex patient conditions. That's where Robotics and Self learning Artificial Intelligence has come to the picture. It is definitely not a substitute for the surgeon. They merely assist the surgeon to ensure that there is accuracy and precision that the naked eye perceives and surgeons can do their best to achieve great results with highest patient satisfaction, every single time, in every type of joint in every patient, every day.

Benefits of Robotics knee replacement

Robotics is being adopted in every field and is being used now to successfully perform knee replacement procedures more precisely and accurately than ever before. Robotic knee replacement helps create a precise real-time image of the knee and then, by using a robotics-assisted hand piece which is operated by the surgeon, relays patient-specific information to the brain box of the robot in the operating room. The process creates a real time 4D model of the joint on the surgical table in a dynamic manner, eliminating the need for any CT scan or MRI prior to the knee operation. It allows surgeons the control to create a patient-specific plan in the Operating Room and the confidence to execute with 100 per cent robotic precision.

The robotic assistance ensures perfect execution of the customised plan. This leads to better implant fixation and longer-lasting implants because of perfect alignment. There is also less bleeding, less removal of bone, and better preservation of natural ligaments and structures that make the patient recover faster after surgery, have a much higher and pain-free range of motion, no muscle strain or instability, and a highly natural feeling so that the patient almost forgets that surgery was even done.

Read the original here:

Robotics in knee replacement - The Hans India

Mentions of robotics within the filings of companies in the automotive industry rose 124% between the first and second quarters of 2021.

In total, the frequency of sentences related to robotics between July 2020 and June 2021 was 24% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings.

When companies in the automotive industry publish annual and quarterly reports, ESG reports and other filings, GlobalData analyses the text and identifies individual sentences that relate to disruptive forces facing companies in the coming years. Robotics is one of these topics - companies that excel and invest in these areas are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges.

To assess whether robotics is featuring more in the summaries and strategies of companies in the automotive industry, two measures were calculated. Firstly, we looked at the percentage of companies which have mentioned robotics at least once in filings during the past twelve months - this was 49% compared to 25% in 2016. Secondly, we calculated the percentage of total analysed sentences that referred to robotics.

Of the 50 biggest employers in the automotive industry, Yamaha Motor Co Ltd was the company which referred to robotics the most between July 2020 and June 2021. GlobalData identified 63 robotics-related sentences in the Japan-based company's filings - 0.9% of all sentences. Denso Corp mentioned robotics the second most - the issue was referred to in 0.6% of sentences in the company's filings. Other top employers with high robotics mentions included Toyoda Gosei Co Ltd, JTEKT Corp and Bridgestone Corp.

Across all companies in the automotive industry the filing published in the second quarter of 2021 which exhibited the greatest focus on robotics came from Yamaha Motor Co Ltd. Of the document's 1,459 sentences, nine (0.6%) referred to robotics.

This analysis provides an approximate indication of which companies are focusing on robotics and how important the issue is considered within the automotive industry, but it also has limitations and should be interpreted carefully. For example, a company mentioning robotics more regularly is not necessarily proof that they are utilising new techniques or prioritising the issue, nor does it indicate whether the company's ventures into robotics have been successes or failures.

In the last quarter, companies in the automotive industry based in Asia were most likely to mention robotics with 0.09% of sentences in company filings referring to the issue. In contrast, companies with their headquarters in Western Europe mentioned robotics in just 0.01% of sentences.

Read the original post:

Filings buzz in the automotive industry: 124% increase in robotics mentions in Q2 of 2021 - just-auto.com

Cleo Robotics is announcing that its palm-fitting Dronut X1 drone, which is designed specifically for indoor operations, is now available to buy commercially. A ducted fan design gives the Dronut its unconventional looks and allows it to fly comfortably near people, in tight spaces, and around sensitive equipment.

To achieve flight stability, this indoor drone uses a thrust vectoring technology that has been patented by Cleo Robotics. The Dronut X1 also comes equipped with some of the best autonomous navigation technologies, powered by Qualcomm Snapdragon and a suite of sensors including LiDAR-powered obstacle detection for operations in GPS-denied environments.

With its propellers completely enclosed, the rugged and portable X1 is made out of carbon fiber composite materials, allowing it to safely bounce off objects and people. This makes the drone ideal for autonomous industrial inspections (tanks, pressure vessels, crawl spaces, etc.) and construction monitoring.

Also read: 550-gram R&D drone can navigate indoors autonomously

Meanwhile, Cleo Robotics says the drone can also be used as a surveillance and reconnaissance (ISR) solution by defense customers. Even law enforcement agencies can benefit from an intelligent indoor drone that can scout areas in advance of deploying officers into high-risk situations. For facility security, the drone can act as a flying surveillance camera.

Weighing less than a pound and measuring only 6.5 inches in diameter, Cleo Robotics stresses its Dronut X1 is the first professional-grade, collision-tolerant, safe-to-touch, intelligent indoor drone that carries advanced payloads and can come in direct contact with people without risk of harm. It can also operate in low-light conditions.

As Omar Eleryan, founder and CEO, Cleo Robotics, sums up:

Built to solve what had been thought of as unsolvable technical challenges with ducted fan aerial vehicles, we developed and tested the Dronut platform through rigorous and innovative engineering. We are excited to see the impact that the Dronut X1 will have on the industries that it is designed to serve. Having worked in the oil industry, I experienced the dangers and costs associated with confined space inspections. The Dronut X1 is the solution that removes the need to risk humans safety on the job.

You can buy the Dronut X1 here for $9,800.

Read more: DJI slashes SDK development kit price by up to 56%

Subscribe to DroneDJ on YouTube for exclusive videos

Read the rest here:

This nontraditional Cleo Robotics indoor drone is now available to buy - DroneDJ

Global leader in the development of highly dexterous mobile robotic systemsmore than doubles footprint to facilitate expansion and initial commercial production

SALT LAKE CITY November 18, 2021 Sarcos Technology and Robotics Corporation(Sarcos) (NASDAQ: STRC and STRCW), a leader in the development of robotic systems that augment humans to enhance productivity and safety, today announced that it has moved into a new headquarters and production facility in the Granary District of Salt Lake City. The move to the new innovative office, lab space, and production facility, comprising more than 60,000 square feet, comes as the company completes the commercialization of its award-winning industrial robotic exoskeleton and teleoperated industrial robotic avatar products.

Sarcos is expecting to increase its headcount by 60-70% over the course of 2022. It expects to start producing the commercial version of itsGuardianXOfull-body, battery-powered industrial exoskeletonandGuardianXTteleoperated dexterous mobile robotic avatar systemat the end of 2022.The new space, which nearly doubles the size of its previous headquarters, includes an extensive test lab and demonstration space for customer use case validation and trials. Sarcos estimates that it will be able to produce between 300 and 500 commercial units of its Guardian XO exoskeleton and Guardian XT robotic system per year at its new facility.

We are thrilled to be in our new, state-of-the-art headquarters, said Ben Wolff, Chairman and CEO, Sarcos. With the significant company growth we are expecting over the next several years, we needed a building that could accommodate additional employees as well initial production of our flagship commercial products.

The new Sarcos headquarters is located at 650 S 500 W. Suite 150, Salt Lake City, UT, 84101, within theINDUSTRYSalt Lake City building. INDUSTRYis a modern office space with two additional locations in Denver and houses a large variety of tenants in addition to Sarcos.The company has signed a 12-year lease with options to extend for up to six additional years. Barb Johnson and Kreg Peterson from CBRE represented Sarcos on the lease transaction.

For more information on Sarcos and its award-winning product portfolio, please visitwww.sarcos.com.

About Sarcos Technology and Robotics Corporation

Sarcos Technology and Robotics Corporation (NASDAQ: STRC and STRCW) is a leader in industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Leveraging more than 30 years of research and development, Sarcos mobile robotic systems, including the GuardianS, GuardianGT, GuardianXO, and GuardianXT, are designed to revolutionize the future of work wherever physically demanding work is done. Sarcos is based in Salt Lake City, Utah. For more information, please visitwww.sarcos.com.

Go here to see the original:

Sarcos Technology and Robotics Corporation Moves into New Headquarters and Production Facility in Salt Lake City - Food Industry Executive

The Danbury High School robotics team competed in its third competition of the season on Nov. 13, with two of its four robots placing third and fifth of 42 competing area teams.

The robotic teams 5150 consist of a handful of students who are given control of the process of creating the robots. The learning style allows them to learn from each other as they are encouraged to help one another without a lot of input from advisors. They are given the opportunity to develop the robots by themselves and dedicate their time to perfecting the robots. For almost 10 years, the DHS Robotics Team, an afterschool program led by Team Advisor Erik Savoyski, has successfully qualified robots for the VEX Robotics world championships, which culminate the season every spring.

At the Nov. 13 competition at Ridgefield High School, DHS Team 5150D finished third, H team placed fifth and teams E and J finished 14 and 34, respectively. Team D was defeated in the final match and took home the tournament finalist award. The Team D robot was also awarded the Design award for the best engineering notebook for an unprecedent third time in a row.

Teams D, H and J currently hold fourth, seventh and 11th places, respectively in robot and programming skills in Southern New England, a separate competition for the most points scored in one minute on an open playing field.

The next robotics competition will be held Nov. 20 at Weston High School.

Read the rest here:

Robotics team places third, fifth in third competition of season - HamletHub